ArticleBMC health services research2024
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patients.
Jeffrey Thomas Yorio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it